Patent Term Application for PALSONIFY (paltusotine), Patent No. 10,875,839

Documents

Comments

Key Dates

Comment Period OpensDec 18, 2025

Type	Title	Posted	Comments	Status
Other	Letter from FDA CDER to U.S. Patent and Trademark Office	Apr 21, 2026	--	--

CDER

Finnegan Henderson

Farabow Garrett and Dunner LLP

Crinetics Pharmaceuticals Inc

Patent Term Application

for PALSONIFY paltusotine

Patent No 10 875 839

OPEN